Julia M M Dantas

Ms. Julia M M Dantas

University of Sherbrooke
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 May 2021 in Fermentation
Verified
Journal Article
Open access
PDF file
JBJean-Baptiste Beigbeder
Jean-Baptiste Beigbeder
JDJulia M M Dantas
Julia M M Dantas
JLJean-Michel Lavoie
Jean-Michel Lavoie
Among the various agro-industrial by-products, sugar beet molasses produced by sugar refineries appear as a potential feedstock for ethanol production through yeast fermentation. A response surface methodology (RSM) was developed to better understand the effect of three process parameters (concentration of nutrient, yeast and initial sugar) on the ethanol productivity using diluted sugar beet molasses and Saccharomyces cerevisiae yeast. The first set of experiments performed at lab-scale indicated that the addition of 4 g/L of nutrient combined with a minimum of 0.2 g/L of yeast as well as a sugar concentration lower than 225 g/L was required to achieve high ethanol productivities (>15 g/L/d). The optimization allowed to considerably reduce the amount of yeast initially introduced in the fermentation substrate while still maximizing both ethanol productivity and yield process responses. Finally, scale-up assays were carried out in 7.5 and 100 L bioreactors using the optimal conditions: 150 g/L of initial sugar concentration, 0.27 g/L of yeast and 4 g/L of nutrient. Within 48 h of incubation, up to 65 g/L of ethanol were produced for both scales, corresponding to an average ethanol yield and sugar utilization rate of 82% and 85%, respectively. The results obtained in this study highlight the use of sugar beet molasses as a low-cost food residue for the sustainable production of bioethanol.

1 August 2021 in Journal of CO2 Utilization
Verified
Journal Article
Closed access
JBJean-Baptiste Beigbeder
Jean-Baptiste Beigbeder
MSMalo Sanglier
Malo Sanglier
JDJulia M M Dantas
Julia M M Dantas
JLJean-Michel Lavoie
Jean-Michel Lavoie

12 February 2021 in Marine Drugs
Verified
Journal Article
Open access
PDF file
NSNayara Sousa da Silva
Nayara Sousa da Silva
NANathalia Araujo
Nathalia Araujo
ASAlessandra Silva
Alessandra Silva
JOJohny Olivera
Johny Olivera
JDJulia M M Dantas
Julia M M Dantas
MPMatheus Pedrosa
Matheus Pedrosa
The global rise of infectious disease outbreaks and the progression of microbial resistance reinforce the importance of researching new biomolecules. Obtained from the hydrolysis of chitosan, chitooligosaccharides (COSs) have demonstrated several biological properties, including antimicrobial, and greater advantage over chitosan due to their higher solubility and lower viscosity. Despite the evidence of the biotechnological potential of COSs, their effects on trypanosomatids are still scarce. The objectives of this study were the enzymatic production, characterization, and in vitro evaluation of the cytotoxic, antibacterial, antifungal, and antiparasitic effects of COSs. NMR and mass spectrometry analyses indicated the presence of a mixture with 81% deacetylated COS and acetylated hexamers. COSs demonstrated no evidence of cytotoxicity upon 2 mg/mL. In addition, COSs showed interesting activity against bacteria and yeasts and a time-dependent parasitic inhibition. Scanning electron microscopy images indicated a parasite aggregation ability of COSs. Thus, the broad biological effect of COSs makes them a promising molecule for the biomedical industry.

Verified
Journal Article
Open access
PDF file
RARafael Caetano Lisboa Castro de Andrade
Rafael Caetano Lisboa Castro de Andrade
NANathalia Araujo
Nathalia Araujo
MTManoela Torres-Rêgo
Manoela Torres-Rêgo
AFAllanny Alves Furtado
Allanny Alves Furtado
ASAlessandra Silva
Alessandra Silva
MPMatheus Pedrosa
Matheus Pedrosa
The search for promising biomolecules such as chitooligosaccharides (COS) has increased due to the need for healing products that act efficiently, avoiding complications resulting from exacerbated inflammation. Therefore, this study aimed to produce COS in two stages of hydrolysis using chitosanases derived from Bacillus toyonensis. Additionally, this study aimed to structurally characterize the COS via mass spectrometry, to analyze their biocompatibility in acute toxicity models in vivo, to evaluate their healing action in a cell migration model in vitro, to analyze the anti-inflammatory activity in in vivo models of xylol-induced ear edema and zymosan-induced air pouch, and to assess the wound repair action in vivo. The structural characterization process pointed out the presence of hexamers. The in vitro and in vivo biocompatibility of COS was reaffirmed. The COS stimulated the fibroblast migration. In the in vivo inflammatory assays, COS showed an antiedematogenic response and significant reductions in leukocyte migration, cytokine release, and protein exudate. The COS healing effect in vivo was confirmed by the significant wound reduction after seven days of the experiment. These results indicated that the presence of hexamers influences the COS biological properties, which have potential uses in the pharmaceutical field due to their healing and anti-inflammatory action.

1 December 2020 in Bioresource Technology Reports
Verified
Journal Article
Closed access
WCWillyan Araújo da Costa
Willyan Araújo da Costa
CPCarlos Eduardo de Araújo Padilha
Carlos Eduardo de Araújo Padilha
JDJulia M M Dantas
Julia M M Dantas
MSMaylla Maria Correia Leite Silva
Maylla Maria Correia Leite Silva
HRHugo Alexandre de Oliveira Rocha
Hugo Alexandre de Oliveira Rocha
ESEveraldo Silvino dos Santos
Everaldo Silvino dos Santos

29 January 2022 in Fermentation
Verified
Journal Article
Open access
PDF file
JDJulia M M Dantas
Julia M M Dantas
ANAndré Álvares Monge Neto
André Álvares Monge Neto
TGThierry Ghislain
Thierry Ghislain
JLJean-Michel Lavoie
Jean-Michel Lavoie
The purpose of this paper is to demonstrate the validity of an alternative route to valorize declassified maple syrups affected by flavor defects such as ropy maple syrup (RMS) and buddy maple syrup (BMS) as feedstocks for ethanol production. An acid hydrolysis treatment (0.1 M, 0.5 M, 5 M, and 10 M) was performed on the RMS to break the polysaccharide chains which are responsible for the flavor defect. The sugars and inhibitors composition of these hydrolysates were analyzed by ion chromatography and ion exclusion chromatography, respectively. Maple syrup samples were fermented by Saccharomyces cerevisiae for 96 h at 30 °C, and ethanol content was measured to determine the kinetic parameters of the process. RMS and BMS demonstrated a good potential to be used as feedstocks to produce ethanol achieving high efficiencies (RMS: 90.08%; BMS: 93.34%). The acid hydrolysis (25 min, 50 °C, with the addition of 5 M sulfuric acid solution) was effective to maximize ethanol production when using RMS as feedstock. To the best of our knowledge, it is the first time that such an approach is used to valorize declassified maple syrups.